These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 3285902)
21. Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables. Buckman TD; Kling A; Sutphin MS; Steinberg A; Eiduson S Psychiatry Res; 1990 Jan; 31(1):1-14. PubMed ID: 1969170 [TBL] [Abstract][Full Text] [Related]
22. Blood platelet monoamine oxidase activity in anergic schizophrenics. Shaskan EG; Becker RE Natl Inst Drug Abuse Res Monogr Ser; 1975 Nov; (3):29-35. PubMed ID: 1233383 [TBL] [Abstract][Full Text] [Related]
23. Paranoid schizophrenia and platelet MAO activity. Baron M; Perlman R; Levitt M Am J Psychiatry; 1980 Nov; 137(11):1465-6. PubMed ID: 7435694 [No Abstract] [Full Text] [Related]
24. Substrate-typic changes of platelet monoamine oxidase activity in sub-types of schizophrenia. Demisch L; von der Mühlen H; Bochnik HJ; Seiler N Arch Psychiatr Nervenkr (1970); 1977 Dec; 224(4):319-29. PubMed ID: 606205 [TBL] [Abstract][Full Text] [Related]
25. Platelet MAO activity in schizophrenia and other psychiatric illnesses. Sullivan J; Stanfield CN; Dackis C Am J Psychiatry; 1977 Oct; 134(10):1098-1103. PubMed ID: 900261 [TBL] [Abstract][Full Text] [Related]
26. Effects of neuroleptics on platelet monoamine oxidase activity. Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230 [TBL] [Abstract][Full Text] [Related]
33. MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients. Mészáros Z; Borcsiczky D; Máté M; Tarcali J; Tekes K; Magyar K J Neural Transm Suppl; 1998; 52():79-85. PubMed ID: 9564610 [TBL] [Abstract][Full Text] [Related]
34. Platelet monoamine oxidase activity: relation to genetic load of schizophrenia. Baron M; Levitt M Psychiatry Res; 1980 Sep; 3(1):69-74. PubMed ID: 6934558 [TBL] [Abstract][Full Text] [Related]
35. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs. Kemali D; Maj M; Ariano MG; Salvati A Encephale; 1985; 11(1):31-4. PubMed ID: 2859981 [TBL] [Abstract][Full Text] [Related]
36. Low platelet MAO activity in chronic schizophrenics: a long-term effect of neuroleptic treatment? Del Vecchio M; Maj M; D'Ambrosio A; Kemali D Psychopharmacology (Berl); 1983; 79(2-3):177-9. PubMed ID: 6133302 [TBL] [Abstract][Full Text] [Related]
37. Platelet monoamine oxidase activity and schizophrenia--a myth that refuses to die? Fleissner A; Seifert R; Schneider K; Eckert W; Fuisting B Eur Arch Psychiatry Neurol Sci; 1987; 237(1):8-15. PubMed ID: 3480800 [TBL] [Abstract][Full Text] [Related]
38. Poor outcome and low platelet MAO activity in chronic schizophrenia. Bierer L; Docherty JP; Young JG; Giller E; Cohen D Am J Psychiatry; 1984 Feb; 141(2):257-60. PubMed ID: 6140867 [TBL] [Abstract][Full Text] [Related]
39. Platelet MAO activity and family history of schizophrenia. Duncavage M; Luchins DJ; Meltzer HY Psychiatry Res; 1982 Aug; 7(1):47-51. PubMed ID: 6957899 [TBL] [Abstract][Full Text] [Related]